OmarFAbou EzzeddineMD

Cardiology • Rochester, MN

Adult Congenital Heart Disease, Heart Failure & Transplantation

Physician

Join to view full profile

Dr. Abou Ezzeddine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abou Ezzeddine's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2015
Mayo Clinic School of Graduate Medical EducationMS, Clinical and Translational Science, 2010 - 2011
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2007 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2007 - 2008
McGill University Faculty of MedicineClass of 2007

Certifications & Licensure

MN State Medical License 2008 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study) Start of enrollment: 2008 Mar 01
Completed
Phase 3
Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study) Start of enrollment: 2008 Sep 01
Completed
Phase 3
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels Start of enrollment: 2010 May 01
Completed
Phase 2
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study Start of enrollment: 2010 Aug 01
Completed
Phase 2
Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors Start of enrollment: 2020 Oct 07
Completed
Not Applicable
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis.
Jennifer M Amadio, Martha Grogan, Eli Muchtar, Francisco Lopez-Jimenez, Zachi I Attia
ESC Heart Failure. 2025-02-01
Amyloidosis and Heart Transplantation in a New Era.
Melissa A Lyle, Juan Maria M Farina, Erin Wiedmeier-Nutor, Vanda Lindpere, Molly Klanderman
Clinical Transplantation. 2025-01-01
1 citations
Biomarkers to Predict Abnormal Technetium-99m Pyrophosphate Scans in Patients With Suspected Transthyretin Amyloidosis.
Laura De Michieli, Omar F AbouEzzeddine, Muhannad A Abbasi, Daniel R Davies, Christopher G Scott
JACC. Cardiooncology. 2025-01-01

Abstracts/Posters

A Proteomic Atlas of Cardiac Amyloidosis
Omar F. abou Ezzeddine, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Professional Memberships

American College of Cardiology - ACC
Member

Other Languages

French, Arabic